S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q2 2023

Avoro Capital Advisors

Period: Q2 2023 Β· Filed: 2023-08-14
View on SEC EDGAR β†—
AUM
$7.37B
Total portfolio value
Positions
43
Reported securities
Top Holding
APLS
13.7% $1.01B
QoQ Changes
+6 / -2
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
APLSAPELLIS PHARMACEUTICALS INC$1.01B13.73%$91.10β€”
13.7%
HZNPHORIZON THERAPEUTICS PLC$720.0M9.77%β€”β€”
9.8%
UTHRUNITED THERAPEUTICS CORP$642.4M8.71%$220.75$555.91+151.8%
8.7%
SRPTSAREPTA THERAPEUTICS INC$530.0M7.19%$114.52$19.28-83.2%
7.2%
ARGXARGENX SE$492.4M6.68%$389.73$939.68+141.1%
6.7%
MDGLMADRIGAL PHARMACEUTICALS INC$350.0M4.75%$231.00$528.10+128.6%
4.8%
BMRNBIOMARIN PHARMACEUTICAL INC$346.7M4.70%$86.68$58.99-31.9%
4.7%
FOLDAMICUS THERAPEUTICS INC$344.1M4.67%β€”β€”
4.7%
SGENSEAGEN INC$338.6M4.59%β€”β€”
4.6%
ASNDASCENDIS PHARMA$319.6M4.34%$89.25$274.50+207.6%
4.3%
ISEEIVERIC BIO INC$316.7M4.30%β€”β€”
4.3%
KRYSKRYSTAL BIOTECH INC$300.6M4.08%$117.40$375.07+219.5%
4.1%
ALNYALNYLAM PHARMACEUTICALS INC$209.9M2.85%$189.94$312.78+64.7%
2.9%
MRTXMIRATI THERAPEUTICS INC$200.7M2.72%β€”β€”
2.7%
XENEXENON PHARMACEUTICALS INC$188.7M2.56%$38.50$60.96+58.3%
2.6%
CBAYCYMABAY THERAPEUTICS INC$112.8M1.53%β€”β€”
1.5%
DICEDICE THERAPEUTICS INC$102.2M1.39%β€”β€”
1.4%
KYMRKYMERA THERAPEUTICS INC$88.6M1.20%$22.99$113.51+393.7%
1.2%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$88.0M1.19%$51.00$18.95-62.8%
1.2%
BCRXBIOCRYST PHARMACEUTICALS INC$84.9M1.15%$7.04$9.84+39.8%
1.1%
NUVLNUVALENT INC$67.5M0.92%$42.17$123.73+193.4%
0.9%
ROIVROIVANT SCIENCES LTD$58.5M0.79%$10.08$35.13+248.5%
0.8%
SNDXSYNDAX PHARMACEUTICALS INC$55.5M0.75%$20.93$21.82+4.3%
0.8%
IOVAIOVANCE BIOTHERAPEUTICS INC$47.2M0.64%$7.04$4.31-38.8%
0.6%
MNKDMANNKIND CORP$37.0M0.50%$4.07$4.52+11.1%
0.5%
RAREULTRAGENYX PHARMACEUTICAL INC$34.6M0.47%$46.13$33.47-27.4%
0.5%
MRNSMARINUS PHARMACEUTICALS INC$34.2M0.46%β€”β€”
0.5%
KURAKURA ONCOLOGY INC$32.9M0.45%$10.58$11.10+4.9%
0.5%
GLUEMONTE ROSA THERAPEUTICS INC$31.1M0.42%$6.85$24.21+253.4%
0.4%
RNAMAVIDITY BIOSCIENCES INC$27.8M0.38%β€”β€”
0.4%

Quarter-on-Quarter Activity

Q2 2023 vs. Q1 2023

New Positions (6)

TickerIssuerNotionalSince Filing
MLTXMOONLAKE IMMUNOTHERAPEUTICS$88.0M-62.8%
ROIVROIVANT SCIENCES LTD$58.5M+248.5%
ARWRARROWHEAD PHARMACEUTICALS INC$12.7M
IKNAIKENA ONCOLOGY INC$10.8M
TALSTALARIS THERAPEUTICS INC$1.5M
AGLEAEGLEA BIOTHERAPEUTICS INC$0.1M

Exited Positions (2)

TickerIssuerNotional
AMLXAMYLYX PHARMACEUTICALS INC$13.9M
XBISPDR SERIES TRUST - S&P BIOTECH$0.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTSAREPTA THERAPEUTICS INC$526.3M+1751.2%-83.2%
ISEEIVERIC BIO INC$314.9M+820.0%
MCRBSERES THERAPEUTICS INC$4.6M+93.1%
KRYSKRYSTAL BIOTECH INC$160.5M+46.3%+219.5%
SRPTSAREPTA THERAPEUTICS INC$26.9M+26.8%-83.2%
ISEEIVERIC BIO INC$151.2M+18.4%
BCRXBIOCRYST PHARMACEUTICALS INC$-2.0M+15.7%+39.8%
VRCAVERRICA PHARMACEUTICALS INC$-0.2M+11.5%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
DICEDICE THERAPEUTICS INC$-11.0M-44.3%
MRSNMERSANA THERAPEUTICS INC$-10.1M-15.6%
NUVLNUVALENT INC$18.2M-15.3%+193.4%
MDGLMADRIGAL PHARMACEUTICALS INC$-53.8M-9.1%+128.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$4.3M-4.6%-38.8%
SGENSEAGEN INC$-26.2M-2.3%
ARGXARGENX SE$12.7M-1.9%+141.1%
← Back to Hedge Funds